Trigger point injection therapy in the management of myofascial temporomandibular pain

Abstract

SummaryObjectives: Myofascial pain is the most common temporomandibular disorder. The objective of this study was to compare the effectiveness of combined treatment modalities in the management of myofascial temporomandibular pain. Methods:Fifty patients (44 female, 6 male) clinically and radiologically diagnosed with myofascial temporomandibular disorder (TMD) were selected for the study and randomly assigned to two groups of 25 patients. Group 1 patients were treated with stabilization splint (SS) and Group 2 patients were treated with trigger point injection combined with SS therapy.Results: Positive improvement in overall signs and symptoms with statistically significant differences was observed in both groups. Group 2 showed significant reduction in visual analogue scale (VAS) scores, and statistical analysis revealed a significant difference between the VAS scores of Group 1 and Group 2 at the 4th and 12th weeks of treatment follow-up (p<0.001). Conclusion:Our results indicate that trigger point injection therapy combined with splint therapy is effective in the management of myofascial TMD pain. Further research, especially randomized controlled trials, should be carried out to ascertain its effectiveness over other treatment modalities.

Effectiveness of Mesotherapy on Temporomandibular Joint Disorders

“…While majority of affected patients will not show or have auto-limited complaints, the best treatment option for chronic and severe patients is not completely established. A lot of treatments had been applied in the past from non-invasive (mobilization, splint, physical modalities and many others) to surgical repair with variable success and does not exist a standard treatment [16][17][18][19].…”

“…MRI (Magnetic resonance imaging) is considered to be the gold standard for diagnose TMJ problems [13]. Conservative therapies remain as the first line management [14][15][16][17][18][19]. In some cases, when problems perpetuate, surgery repair may be required [20].…”

Скелетно-М’язові Больові Синдроми: Від Патогенетичних Особливостей До Раціональних Терапевтичних Підходів

“…Значительной эффективностью при СМБ обладают инвазивные методы воздействия -медикаментозные блокады триггерных точек. Инъекционный раствор может включать анальгетик (новокаин), НПВС, кортикостероиды, ботулотоксин, кроме того, возможно выполнение безмедикаментозной («сухой») пункции триггерной точки [9,10]. После выполнения блокады (пункции) триггерной точки основная симптоматика (локальная и отраженная боль, симптом прыжка) исчезают, болезненный мышечный тяж расслабляется.…”

Dolor miofascial en el territorio craneocervical: una revisión de la patología y su relación con polimorfismos genéticos del sistema GABAérgico

“…Los TTM son reconocidos como el dolor orofacial persistente más común, no presentando diferencias entre grupos poblacionales (14). Dentro de los TTM el dolor miofascial es el más frecuente (12), afectando a más Iturriaga V, Bornhardt T, Oporto G..…”